Log in

NASDAQ:KIDSOrthopediatrics Stock Price, Forecast & News

$44.11
+0.01 (+0.02 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$43.46
Now: $44.11
$45.10
50-Day Range
$40.80
MA: $46.19
$50.20
52-Week Range
$28.19
Now: $44.11
$51.48
Volume125,600 shs
Average Volume138,095 shs
Market Capitalization$785.95 million
P/E RatioN/A
Dividend YieldN/A
Beta0.69
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. It offers trauma and deformity procedures; scoliosis procedures for the treatment of spinal deformity; and sports medicine procedures. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.
Read More
Orthopediatrics logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$72.55 million
Book Value$8.51 per share

Profitability

Net Income$-13,730,000.00

Miscellaneous

Employees80
Market Cap$785.95 million
Next Earnings Date8/5/2020 (Estimated)
OptionableNot Optionable

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

How has Orthopediatrics' stock been impacted by COVID-19 (Coronavirus)?

Orthopediatrics' stock was trading at $39.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, KIDS shares have increased by 11.0% and is now trading at $44.11. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Orthopediatrics?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthopediatrics.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Orthopediatrics.

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) posted its earnings results on Tuesday, May, 5th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.25) by $0.05. The company earned $16.36 million during the quarter, compared to analysts' expectations of $16.95 million. Orthopediatrics had a negative net margin of 21.08% and a negative return on equity of 12.26%. View Orthopediatrics' earnings history.

What guidance has Orthopediatrics issued on next quarter's earnings?

Orthopediatrics updated its second quarter 2020 IntraDay earnings guidance on Tuesday, June, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $12.74-12.74 million, compared to the consensus revenue estimate of $10.73 million.

What price target have analysts set for KIDS?

6 brokers have issued twelve-month price targets for Orthopediatrics' stock. Their forecasts range from $48.00 to $55.00. On average, they expect Orthopediatrics' share price to reach $51.67 in the next twelve months. This suggests a possible upside of 17.1% from the stock's current price. View analysts' price targets for Orthopediatrics.

Has Orthopediatrics been receiving favorable news coverage?

News stories about KIDS stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Orthopediatrics earned a news sentiment score of 0.7 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Orthopediatrics.

Who are some of Orthopediatrics' key competitors?

What other stocks do shareholders of Orthopediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthopediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Walt Disney (DIS), Editas Medicine (EDIT), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the following people:
  • Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
  • Mr. Fred L. Hite, CFO & Director (Age 51)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
  • Mr. David R. Bailey, Exec. VP (Age 40)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $44.11.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $785.95 million and generates $72.55 million in revenue each year. The company earns $-13,730,000.00 in net income (profit) each year or ($0.87) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.

What is Orthopediatrics' official website?

The official website for Orthopediatrics is www.orthopediatrics.com.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.